Countagen

About:

Countagen offers consumable reagent kits that allow users to analyze gene editing efficiency and specificity.

Top Investors: Almi Invest

Description:

Countagen offers consumable reagent kits that allow users to analyze gene editing efficiency and specificity with the same high precision as high-end instrumentation.

Total Funding Amount:

11.5M SEK

Headquarters Location:

Solna, Stockholms Lan, Sweden

Founded Date:

2020-01-01

Contact Email:

info(AT)countagen.com

Founders:

Felix Neumann, Mats Nilsson, Mårten Winge

Number of Employees:

1-10

Last Funding Date:

2022-06-27

IPO Status:

Private

Industries: